Aptamer Innovations
Aptamer Innovations (AI) is a biotech startup specializing in RNA therapeutic tools and diagnostic technologies. Founded in 2020 by scientists from Simon Fraser University, AI develops and commercializes rapid, robust RNA imaging and purification technologies leveraging patented fluorescent nucleic acid technology. Their core expertise is based on over 20 years of RNA research experience. AI commercializes variants of Mango technology for academic and industrial use, focusing on RNA-aptamer based technologies for RNA imaging and purification, and single-molecule tracking for super-resolution imaging. The company addresses the need for rapid RNA detection highlighted by COVID-19, aiming to be a leader in RNA technology with peer-reviewed developments adopted by the RNA research community.
Aptamer Innovations
Aptamer Innovations (AI) is a biotech startup specializing in RNA therapeutic tools and diagnostic technologies. Founded in 2020 by scientists from Simon Fraser University, AI develops and commercializes rapid, robust RNA imaging and purification technologies leveraging patented fluorescent nucleic acid technology. Their core expertise is based on over 20 years of RNA research experience. AI commercializes variants of Mango technology for academic and industrial use, focusing on RNA-aptamer based technologies for RNA imaging and purification, and single-molecule tracking for super-resolution imaging. The company addresses the need for rapid RNA detection highlighted by COVID-19, aiming to be a leader in RNA technology with peer-reviewed developments adopted by the RNA research community.